Non-covalent BTK inhibitor found effective in some heavily pretreated patients with CLL.
Read MoreStudy Explores VTE Risk Among Patients with Multiple Myeloma During the Peri-Transplant Period
A recent study uncovered risk factors for venous thromboembolism among patients with multiple myeloma post autologous hematopoietic cell transplant.
Measuring Residual Disease in Leukemias: Improving on Current Assays is a Focus
Next-generation sequencing may improve upon existing methods for measuring minimal residual disease in patients with AML or myelodysplastic syndrome who have received a allogeneic hematopoietic stem cell transplant.
Reducing Radiation-Related Toxicities with CPAP Machines
Researchers are studying the use of CPAP machines during radiation to reduce the chance of side effects to the heart and lungs.
Increased Risk of Stroke, Bleeding and Atrial Fibrillation in Older CLL Patients Treated with Ibrutinib
A new study found older adults with CLL have increased risk of adverse events such as atrial fibrillation.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Enfortumab Plus Pembrolizumab May Represent New First-Line Standard in Advanced Urothelial Cancer
Long-term results of a study found combination therapy safe and effective in patients with metastatic urothelial carcinoma or locally advanced disease who are ineligible for cisplatin.
New Blood Test May Help Identify Lung Cancers Earlier
A new blood test under development could provide early screening for lung cancer.
New Risk Calculator Bests Other Clinical Measures in Predicting Overall Survival of Patients with Non-Small Cell Lung Cancer
New risk calculator aids clinicians in supporting patients with non-small cell lung cancer
Curbing Thrombosis in Patients with Cancer
New study aims to uncover potential target for preventing blood clots in patients being treated for cancer.
Population-Based Analysis Highlights Disparities in Lung Cancer Mortality in U.S.
Study sheds light on health disparities in patients with lung cancer.
Luspatercept Shows Promise as Treatment for Anemia in Patients With Myelofibrosis
A recent study found the medication luspatercept helped reduce anemia and transfusion dependence in patients with myelofibrosis.